本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

15.24
+0.42002.83%
盘后15.240.00000.00%18:19 EDT
成交量:119.68万
成交额:1,838.05万
市值:16.03亿
市盈率:-9.84
高:15.60
开:15.11
低:14.97
收:14.82
数据加载中...
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/02

重要事件披露

Form 8-K - Current report
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

重要事件披露

Form 8-K - Current report
2024/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]